How did Linnea start and how did they make it to obtain license for API THC?
The development, production, and marketing of botanical extracts, natural ingredients, and active compounds are the areas of expertise of the Swiss company Linnea. Their products are for the pharmaceutical, cosmetic, and food industries. The company was established in 1993, and its headquarters are in the canton of Zurich’s Bachenbülach. A Linnea’s product line include a wide variety of natural extracts and components. These include bilberry, ginkgo, green tea, and grape seed extracts, as well as different natural tastes and perfumes. For clients who demand customized solutions, the business also provides custom development and production services.
Linnea’s route to obtaining license for API THC
Linnea takes pride in its commitment to sustainability and environmental care. It has taken a number of steps to lessen its influence on the environment, including adopting renewable energy sources and cutting back on waste production. Further, the business has certifications for ISO 9001, ISO 14001, and ISO 22000. They prove that it complies to strict quality, environmental, and food safety management systems.
Growing interest in cannabis and its derivatives, such as THC and CBD, as potential therapeutic agents has driven more investment and study in the marijuana industry in recent years. It’s possible that Linnea entered the cannabis industry because it saw an opportunity to diversify its product line. However also to boost its knowledge of the natural extracts and active substances market. This may be especially given Switzerland’s supportive regulatory environment for cannabis-related research and development.
This Swiss-based business has been granted permission to manufacture and export active pharmaceutical ingredients (APIs) that contain significant amounts of THC. They received the license from Swissmedic, the Swiss Agency for Medicinal Products. Thanks to this Linnea may use to produce and export API containing THC for therapeutic purposes. Linnea has long produced botanical extracts for the pharmaceutical industry. The new license will enable the business to expand its product line to include THC-based items.
Since there are several other businesses in Switzerland that specialize on the research and production of botanical extracts, natural ingredients, and active substances for the pharmaceutical, cosmetic, and food industries, Linnea operates in a crowded market. In order to remain competitive, the company must distinguish itself by its product offerings, quality, and service. Linnea will be able to strengthen its product offers and competitiveness in the international pharmaceutical industry due to the license.